Codes / ICD10CM / T39.315A

T39.315A Adverse effect of propionic acid derivatives, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of propionic acid derivatives, initial encounter (ICD-10-CM Code: T39.315A)

Summary

This condition describes an adverse reaction to propionic acid derivatives, a class of nonsteroidal anti-inflammatory drugs (NSAIDs) used for pain relief, inflammation reduction, and fever management. The code applies to the initial encounter when a patient experiences harm from these medications, such as hypersensitivity, toxicity, or unintended side effects. Examples include drugs like ibuprofen or naproxen.

Causes

Adverse effects may result from hypersensitivity reactions, excessive dosage, chronic use, or interactions with other medications. These reactions can occur even at therapeutic doses, particularly in patients with preexisting conditions or genetic predispositions.

Risk Factors

  • Older age or impaired renal/hepatic function.
  • Concurrent use of alcohol or other drugs (e.g., anticoagulants).
  • History of gastrointestinal, renal, or hepatic disease.
  • Genetic factors affecting drug metabolism.

Symptoms

  • Gastrointestinal: nausea, vomiting, abdominal pain, or bleeding.
  • Neurological: dizziness, headache, or confusion.
  • Renal: decreased urine output or acute kidney injury.
  • Dermatological: rash, itching, or Stevens-Johnson syndrome (rare).

Diagnosis

Diagnosis involves clinical evaluation of symptoms, medication history, and exclusion of other causes. Laboratory tests (e.g., renal function, liver enzymes) may assess organ involvement. Documentation should specify the propionic acid derivative and the nature of the adverse effect.

Treatment Options

Treatment focuses on symptom management and discontinuing the offending drug. Supportive care (e.g., hydration, antiemetics) may be provided. Severe reactions (e.g., anaphylaxis) require emergency intervention, such as epinephrine or corticosteroids.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most mild cases resolve with drug discontinuation. Follow-up ensures resolution of symptoms and monitoring for delayed complications (e.g., renal impairment).

Complications

  • Gastrointestinal bleeding or perforation.
  • Acute kidney injury or chronic renal failure.
  • Severe hypersensitivity reactions (e.g., anaphylaxis).
  • Hepatic toxicity in rare cases.

Lifestyle & Prevention

  • Avoid propionic acid derivatives if prior adverse reactions occurred.
  • Use alternative pain relievers (e.g., acetaminophen) when appropriate.
  • Follow dosing instructions and avoid combining NSAIDs.
  • Store medications securely to prevent accidental ingestion.

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., difficulty breathing, chest pain, or uncontrolled bleeding). Contact a healthcare provider for persistent or worsening reactions, even if mild.

Tips for Medical Coders

Document the specific propionic acid derivative and the nature of the adverse effect. For initial encounters, ensure the "initial encounter" character is used. Code T39.315A is for the initial phase of treatment; subsequent encounters use different characters. Verify no intent of self-harm or poisoning is documented, as these require separate codes.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T39.315A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.